Tests outcomes in early inflammatory joint arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at how early inflammatory joint diseases behave over time, especially early rheumatoid arthritis. It may help doctors better predict prognosis and tailor care for people with new symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with early inflammatory arthritis or early rheumatoid arthritis
- Your arthritis symptoms started recently (early stage)
- You can understand the study and sign consent (or have a way to consent)
- Your joint problem is not caused by an infection
- Your joint problem is not caused by crystal-related arthritis (like gout)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study looks at lung health in people with early rheumatoid arthritis (RA). It may help doctors understand how RA affects the lungs soon after diagnosis and guide better care.
This study follows patients with inflammatory arthritis (rheumatoid arthritis or spondyloarthritis) to learn more about how well biologic or targeted therapies work. If you have tried standard treatments without enough relief, this may help researchers improve future care.
This study tests if a home-based exercise program, combined with anti-inflammatory strategies, can help people newly diagnosed with rheumatoid arthritis manage their symptoms and improve health. It's a remote program, so you can participate from home.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
This study is testing whether a simple blood test can help predict how well patients respond to anti-TNF alpha treatments (like Humira or Enbrel) for rheumatoid arthritis. If successful, this could help doctors choose the right medication sooner, saving you time and improving your quality of life.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.